• 2023
  Torres J, Touati E, Mitochondrial Function in Health and Disease: Responses to Helicobacter pylori Metabolism and Impact in Gastric Cancer Development., Curr Top Microbiol Immunol 2023 ; 444(): 53-81.
• 2022
  Alikhani M, Touati E, Karimipoor M, Vosough M, Mohammadi M, Mitochondrial DNA Copy Number Variations in Gastrointestinal Tract Cancers: Potential Players., J Gastrointest Cancer 2022 Sep; 53(3): 770-781.
• 2021
  Salillas S, Galano-Frutos JJ, Mahía A, Maity R, Conde-Giménez M, Anoz-Carbonell E, Berlamont H, Velazquez-Campoy A, Touati E, Mamat U, Schaible UE, Gálvez JA, Díaz-de-Villegas MD, Haesebrouck F, Aínsa JA, Sancho J, Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies., Int J Mol Sci 2021 Sep; 22(18): .
• 2021
  Bazin T, Krebs A, Jobart-Malfait A, Camilo V, Michel V, Benezeth Y, Marzani F, Touati E, Lamarque D, , Multimodal imaging as optical biopsy system for gastritis diagnosis in humans, and input of the mouse model., EBioMedicine 2021 Jul; 69(): 103462.
• 2021
  Alikhani M, Touati E, Karimipoor M, Vosough M, Eybpoosh S, Mohammadi M, Dynamic Changes of Mitochondrial DNA Copy Number in Gastrointestinal Tract Cancers: A Systematic Review and Meta-Analysis., Cancer Invest 2021 Feb; 39(2): 163-179.
• 2020
  Bazin T, Martinez-Herrera SE, Jobart-Malfait A, Benezeth Y, Boffety M, Julié C, Emile JF, Michel V, Goudail F, Touati E, Marzani F, Lamarque D, , Multispectral imaging detects gastritis consistently in mouse model and in humans., Sci Rep 2020 11; 10(1): 20047.
• 2020
  Henriques PC, Costa LM, Seabra CL, Antunes B, Silva-Carvalho R, Junqueira-Neto S, Maia AF, Oliveira P, Magalhães A, Reis CA, Gartner F, Touati E, Gomes J, Costa P, Martins MCL, Gonçalves IC, , Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice., Acta Biomater 2020 09; 114(): 206-220.
• 2020
  Costa L, Corre S, Michel V, Le Luel K, Fernandes J, Ziveri J, Jouvion G, Danckaert A, Mouchet N, Da Silva Barreira D, Torres J, Camorlinga M, D'Elios MM, Fiette L, De Reuse H, Galibert MD, Touati E, , USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis., Gut 2020 09; 69(9): 1582-1591.
• 2020
  Denic M, Touati E, De Reuse H, , Review: Pathogenesis of Helicobacter pylori infection., Helicobacter 2020 Sep; 25 Suppl 1(): e12736.
• 2020
  Denic M, Touati E, De Reuse H., Pathogenesis of Helicobacter pylori infection, Helicobacter 2020;00:e12736..
• 2020
  Bounder G, Jouimyi MR, Boura H, Touati E, Michel V, Badre W, Jouhadi H, Kadi M, Eljihad M, Benomar H, Kettani A, Lebrazi H, Maachi F, , Associations of the -238(G/A) and -308(G/A) TNF-α Promoter Polymorphisms and TNF-α Serum Levels with the Susceptibility to Gastric Precancerous Lesions and Gastric Cancer Related to Helicobacter pylori Infection in a Moroccan Population., Asian Pac J Cancer Prev 2020 Jun; 21(6): 1623-1629.
• 2019
  Salillas S, Alías M, Michel V, Mahía A, Lucía A, Rodrigues L, Bueno J, Galano-Frutos JJ, De Reuse H, Velázquez-Campoy A, Carrodeguas JA, Sostres C, Castillo J, Aínsa JA, Díaz-de-Villegas MD, Lanas Á, Touati E, Sancho J, , Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori-Infected Mice., J Med Chem 2019 07; 62(13): 6102-6115.
• 2019
  Kotilea K, Bontems P, Touati E, Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection, Adv. Exp. Med. Biol. 2019 Apr;.
• 2018
  Alvarez MC, Fernandes J, Michel V, Touati E, Ribeiro ML, Effect of Helicobacter pylori Infection on GATA-5 and TFF1 Regulation, Comparison Between Pediatric and Adult Patients, Dig. Dis. Sci. 2018 11;63(11):2889-2897.
• 2017
  Chatre L, Fernandes J, Michel V, Fiette L, Avé P, Arena G, Jain U, Haas R, Wang TC, Ricchetti M, Touati E, , Helicobacter pylori targets mitochondrial import and components of mitochondrial DNA replication machinery through an alternative VacA-dependent and a VacA-independent mechanisms., Sci Rep 2017 Nov; 7(1): 15901.
• 2017
  Camilo V, Sugiyama T, Touati E, Pathogenesis of Helicobacter pylori infection, Helicobacter 2017 Sep;22 Suppl 1.
• 2017
  Majlessi L, Sayes F, Bureau JF, Pawlik A, Michel V, Jouvion G, Huerre M, Severgnini M, Consolandi C, Peano C, Brosch R, Touati E, Leclerc C, Colonization with Helicobacter is concomitant with modified gut microbiota and drastic failure of the immune control of Mycobacterium tuberculosis, Mucosal Immunol 2017 Sep;10(5):1178-1189.
• 2015
  Matak P, Heinis M, Mathieu JR, Corriden R, Cuvellier S, Delga S, Mounier R, Rouquette A, Raymond J, Lamarque D, Emile JF, Nizet V, Touati E, Peyssonnaux C, Myeloid HIF-1 is protective in Helicobacter pylori-mediated gastritis, J. Immunol. 2015 Apr;194(7):3259-66.
• 2014
  Fernandes J, Michel V, Camorlinga-Ponce M, Gomez A, Maldonado C, De Reuse H, Torres J, Touati E, Circulating mitochondrial DNA level, a noninvasive biomarker for the early detection of gastric cancer, Cancer Epidemiol. Biomarkers Prev. 2014 Nov;23(11):2430-8.
• 2013
  Correia M, Casal S, Vinagre J, Seruca R, Figueiredo C, Touati E, Machado JC, Helicobacter pylori’s cholesterol uptake impacts resistance to docosahexaenoic acid, Int. J. Med. Microbiol. 2014 May;304(3-4):314-20.
• 2013
  Correia M, Michel V, Osório H, El Ghachi M, Bonis M, Boneca IG, De Reuse H, Matos AA, Lenormand P, Seruca R, Figueiredo C, Machado JC, Touati E, Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid, PLoS ONE 2013;8(4):e60657.
• 2013
  Correia M, Michel V, Osório H, El Ghachi M, Bonis M, Boneca IG, De Reuse H, Matos AA, Lenormand P, Seruca R, Figueiredo C, Machado JC, Touati E., Crosstalk between Helicobacter pylori and gastric epithelial cells is impaired by docosahexaenoic acid., PLoS One. 2013;8(4):e60657. doi: 10.1371/journal.pone.0060657.
• 2012
  da Silva CR, Michel V, Genovese S, Prévost MC, Epifano F, Touati E, Anti-Helicobacter pylori activities of natural isopentenyloxycinnamyl derivatives from Boronia pinnata, Nat Prod Commun 2012 Oct;7(10):1347-50.
• 2012
  Gomes J, Magalhães A, Carvalho AS, Hernandez GE, Papp SL, Head SR, Michel V, David L, Gärtner F, Touati E, Reis CA, Glycophenotypic alterations induced by Pteridium aquilinum in mice gastric mucosa: synergistic effect with Helicobacter pylori infection, PLoS ONE 2012;7(6):e38353.
• 2012
  Correia M, Michel V, Matos AA, Carvalho P, Oliveira MJ, Ferreira RM, Dillies MA, Huerre M, Seruca R, Figueiredo C, Machado JC, Touati E, Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization, PLoS ONE 2012;7(4):e35072.
• 2011
  Gomes J, Magalhães A, Michel V, Amado IF, Aranha P, Ovesen RG, Hansen HC, Gärtner F, Reis CA, Touati E, Pteridium aquilinum and its ptaquiloside toxin induce DNA damage response in gastric epithelial cells, a link with gastric carcinogenesis, Toxicol. Sci. 2012 Mar;126(1):60-71.
• 2010
  Touati E, When bacteria become mutagenic and carcinogenic: lessons from H. pylori, Mutat. Res. 2010 Nov;703(1):66-70.
• 2010
  Bussière FI, Michel V, Mémet S, Avé P, Vivas JR, Huerre M, Touati E, H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression, Cell. Microbiol. 2010 Aug;12(8):1124-33.
• 2009
  Costa AC, Figueiredo C, Touati E, Pathogenesis of Helicobacter pylori infection, Helicobacter 2009 Sep;14 Suppl 1:15-20.
• 2009
  Touati E, Michel V, Correia M, Menghini L, Genovese S, Curini M, Epifano F, Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization, J. Antimicrob. Chemother. 2009 Jul;64(1):210-1.
• 2009
  Machado AM, Figueiredo C, Touati E, Máximo V, Sousa S, Michel V, Carneiro F, Nielsen FC, Seruca R, Rasmussen LJ, Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells, Clin. Cancer Res. 2009 May;15(9):2995-3002.
• 2008
  Vivas JR, Regnault B, Michel V, Bussière FI, Avé P, Huerre M, Labigne A, D' Elios MM, Touati E, Interferon gamma-signature transcript profiling and IL-23 upregulation in response to Helicobacter pylori infection, Int J Immunopathol Pharmacol 2008 Jul-Sep;21(3):515-26.
• 2007
  Orsini B, Vivas JR, Ottanelli B, Amedei A, Surrenti E, Galli A, Milani S, Pinzani P, Del Prete G, Surrenti C, Baldari CT, Touati E, D' Elios MM, Human gastric epithelium produces IL-4 and IL-4delta2 isoform only upon Helicobacter pylori infection, Int J Immunopathol Pharmacol 2007 Oct-Dec;20(4):809-18.
• 2006
  Touati E, Michel V, Thiberge JM, Avé P, Huerre M, Bourgade F, Klungland A, Labigne A, Deficiency in OGG1 protects against inflammation and mutagenic effects associated with H. pylori infection in mouse, Helicobacter 2006 Oct;11(5):494-505.
• 2006
  Quillardet P, Arrault X, Michel V, Touati E, Organ-targeted mutagenicity of nitrofurantoin in Big Blue transgenic mice, Mutagenesis 2006 Sep;21(5):305-11.
• 2003
  Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, Labigne A, Chronic Helicobacter pylori infections induce gastric mutations in mice, Gastroenterology 2003 May;124(5):1408-19.
• 2002
  Hofnung M, Quillardet P, Michel V, Touati E, Genotoxicity of 2-nitro-7-methoxy-naphtho[2,1-b]furan (R7000): a case study with some considerations on nitrofurantoin and nifuroxazide, Res. Microbiol. 2002 Sep;153(7):427-34.
• 2002
  Arrault X, Michel V, Quillardet P, Hofnung M, Touati E, Comparison of kinetics of induction of DNA adducts and gene mutations by a nitrofuran compound, 7-methoxy-2-nitronaphtho[2,1-b]furan (R7000), in the caecum and small intestine of Big Blue mice, Mutagenesis 2002 Jul;17(4):353-9.